Žilvinas DambrauskasŽilvinas Dambrauskas, MD, PhD, MD, PhDDepartment of SurgeryDepartment of Surgery
Lithuanian University of Health SciencesLithuanian University of Health Sciences20120122--1010--0101
0%
5%
10%
15%
20%
Pre
vale
nce
of
SS
I P
reva
len
ce o
f S
SI ((
%%))
Staphyl
ococc
us
aure
us
Coagula
se-n
egat
ive
Staphyl
ococc
us
Entero
cocc
us sp
p.
Escher
ichia
coli
Pseudom
onas
aeru
ginosa
Entero
bacte
r spp.
1. Nichols RL. Preventing surgical site infections: a surgeon’s perspective. Emerg Infect Dis. 2001;7:220–224.2. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm. 1999;56:1839–1888.3. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Am J Infect Control. 1999;27:97–134.388.
www.nice.org.uk/CG74
McDonald M et al. McDonald M et al. Aust NZ J SurgAust NZ J Surg. 1998;68:388–396. Adapted with permission from Blackwell Synergy © 1998.. 1998;68:388–396. Adapted with permission from Blackwell Synergy © 1998.
0.01
0.1
1
10
100
All
stu
die
s,
fix
ed
All
stu
die
s,
fix
ed
All
stu
die
s,
ran
do
mA
ll s
tud
ies
, ra
nd
om
Mu
lti
> 2
4h
Mu
lti
> 2
4h
Mu
lti
Mu
lti <
< 2
4h
24
h
Fav
ors
sin
gle
do
seF
avo
rs s
ing
le d
ose
Fav
ors
mu
ltip
le d
ose
Fav
ors
mu
ltip
le d
ose
www.nice.org.uk/CG74
Infe
ctio
ns, %
Infe
ctio
ns, %
Hours From IncisionHours From Incision
14/36914/369
5/6995/699
5/1,0095/1,009
2/1802/180
1/611/61
1/411/411/471/47
15/44115/441
00
11
22
33
44
≤–≤–33 >–2>–2 >–1>–1 00 11 22 33 44 ≥≥55
Classen DC et al. Classen DC et al. N Engl J MedN Engl J Med. 1992;326:281–286. Copyright © 1992 Massachusetts Medical Society. All rights reserved.. 1992;326:281–286. Copyright © 1992 Massachusetts Medical Society. All rights reserved.
www.nice.org.uk/CG74
Single effective I/V dose (I A) 20-60 min before incision (induction of
anaesthesia) Second dose could be used if :
surgery > 3-4 hr blood loss > 1500 ml
Further use of AB after 24 hr from prophylaxis is justified only in patients with high risk of septic complications (treatment only!)
Calise F et al. Perioperative antibiotic prophylaxis in adults. Outline of the principal recommendations. National reference guidelines. Minerva Anestesiol. 2009 Sep;75(9):543-7, 548-52. English, Italian. PubMed PMID: 19644438.
www.nice.org.uk/CG74
Type of SurgeryType of Surgery Recommended ABRecommended AB AlternativeAlternative
Esophagectomy, Esophagectomy, gastrectromygastrectromy
Cefazolin 2 gCefazolin 2 g Cefuroxime 1,5 gCefuroxime 1,5 g
Stomach and/or Stomach and/or small intestinesmall intestine
Cefazolin 2 gCefazolin 2 gMetronidazole 0.5 - 1 gMetronidazole 0.5 - 1 g
Cefuroxime 1,5 gCefuroxime 1,5 g
HPB surgeryHPB surgery Cefazolin 2 gCefazolin 2 gMetronidazole 0.5 - 1 gMetronidazole 0.5 - 1 g
Clindamycin 600 mgClindamycin 600 mg
AppendectomyAppendectomy Cefazolin 2 gCefazolin 2 gMetronidazole 0.5 - 1 gMetronidazole 0.5 - 1 g
Gentamycin 240 mg, Gentamycin 240 mg, Metronidazole 0.5 gMetronidazole 0.5 g
ColorectalColorectal Cefazolin 2 gCefazolin 2 gMetronidazole 0.5 - 1 gMetronidazole 0.5 - 1 g
Gentamycin 240 mg, Gentamycin 240 mg, Metronidazole 0.5 gMetronidazole 0.5 g
Penetrating Penetrating traumatrauma
Penicilin 5 m, Penicilin 5 m, Gentamycin 240 mg, Gentamycin 240 mg, Metronidazole 0.5 gMetronidazole 0.5 g
Cefuroxime 1,5 gCefuroxime 1,5 gMetronidazole 0.5 - 1 Metronidazole 0.5 - 1
gg
Hernia repairHernia repair Cefazolin 2 gCefazolin 2 g Clindamycin 600 mgClindamycin 600 mg
Breast surgeryBreast surgery Cefazolin 2 gCefazolin 2 g Clindamycin 600 mgClindamycin 600 mg
Indicator No. 1 % of patients, who received AB within 1 hr prior to incision
Indicator No. 2 % of patients, who received AB based on the Guidelines
Indicator No. 3 % of patients, who received no AB after 24 hr